Effects of Combination Therapy of a CDK4/6 and MEK Inhibitor in Diffuse Midline Glioma Preclinical Models
Yusuke Tomita, Gabrielle Link, Yi Ge, Emma R.H. Gold, Herminio Joey Cardona, Megan M. Romero, Samantha Gadd, Jun Watanabe, Eita Uchida, Rintaro Hashizume, Yoshihiro Tanaka, Nozomu Takata, Gonzalo Piñero, Dolores Hambardzumyan, Ivan Spasojević, , Oren Josh Becher
This study evaluates combination therapy of CDK4/6 and MEK inhibitors in DMG models, finding survival benefits in GEM but not PDX models.
PLoS ONE · Dec 22, 2025Peer-reviewedCancer Biology